Dexcom (DXCM) Non-Current Assets (2010 - 2026)
Dexcom's (DXCM) quarterly Non-Current Assets came in at $2.4 billion in Q2 2026, up 3.13% year-over-year from $2.3 billion in Q2 2025, and up 2.92% quarter-over-quarter from $2.3 billion in Q1 2026.
Analysis
Dexcom (DXCM) Non-Current Assets (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Non-Current Assets for 17 consecutive years, with $2.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 3.13% year-over-year to $2.4 billion in Q2 2026; TTM through Jun 2026 was $9.3 billion, a 5.57% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 5.66% from the prior year.
- Non-Current Assets was $2.4 billion for Q2 2026 at Dexcom, up from $2.3 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $2.4 billion in Q2 2026 and troughed at $1.3 billion in Q1 2022.
- A 5-year average of $1.9 billion and a median of $1.9 billion in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 38.71% in 2022 and climbed 3.13% in 2026, its largest moves.
- Over 5 years, Non-Current Assets stood at $1.7 billion in 2022, then increased by 6.72% to $1.8 billion in 2023, then gained by 18.74% to $2.2 billion in 2024, then rose by 5.66% to $2.3 billion in 2025, then rose by 2.69% to $2.4 billion in 2026.
- The last three Non-Current Assets figures came in at $2.4 billion (Q2 2026), $2.3 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 17.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Bn |
| Mar 31, 2026 | 2.30 Bn |
| Dec 31, 2025 | 2.31 Bn |
| Sep 30, 2025 | 2.28 Bn |
| Jun 30, 2025 | 2.30 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.18 Bn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.86 Bn |
| Dec 31, 2023 | 1.84 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.75 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Sep 30, 2022 | 1.50 Bn |
| Jun 30, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 1.12 Bn |